-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Decibel Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2020 to Q2 2023.
- Decibel Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was $80K, a 111% increase year-over-year.
- Decibel Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2023 was $283K, a 85.1% decline year-over-year.
- Decibel Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $240K, a 86.6% decline from 2021.
- Decibel Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $1.8M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)